15116053

Source:http://linkedlifedata.com/resource/pubmed/id/15116053

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0000956, umls-concept:C0031325, umls-concept:C0851347
pubmed:issue	5
pubmed:dateCreated	2004-4-29
pubmed:abstractText	The aim of this study was to investigate the respective contribution of the different cytochrome P450 (CYP) 2C9 genetic polymorphisms to the interindividual variability of acenocoumarol pharmacodynamic response.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372741
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acenocoumarol, http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/Factor VII, http://linkedlifedata.com/resource/pubmed/chemical/NAD(P)H Dehydrogenase (Quinone), http://linkedlifedata.com/resource/pubmed/chemical/NQO1 protein, human
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0009-9236
pubmed:author	pubmed-author:BeaunePhilippe HPH, pubmed-author:BecquemontLaurentL, pubmed-author:BodinLaurentL, pubmed-author:DubertLilianeL, pubmed-author:Funck-BrentanoChristianC, pubmed-author:JaillonPatriceP, pubmed-author:Laurent-PuigPierreP, pubmed-author:LoriotMarie-AnneMA, pubmed-author:MorinSandrineS, pubmed-author:RobertAnnieA, pubmed-author:StrabachSorayaS, pubmed-author:ThijssenHenk H WHH, pubmed-author:TregouetDavid-AlexandreDA, pubmed-author:VerstuyftCélineC
pubmed:issnType	Print
pubmed:volume	75
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	403-14
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15116053-Acenocoumarol, pubmed-meshheading:15116053-Administration, Oral, pubmed-meshheading:15116053-Adolescent, pubmed-meshheading:15116053-Adult, pubmed-meshheading:15116053-Aged, pubmed-meshheading:15116053-Alleles, pubmed-meshheading:15116053-Anticoagulants, pubmed-meshheading:15116053-Area Under Curve, pubmed-meshheading:15116053-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:15116053-DNA Primers, pubmed-meshheading:15116053-Factor VII, pubmed-meshheading:15116053-Female, pubmed-meshheading:15116053-France, pubmed-meshheading:15116053-Genotype, pubmed-meshheading:15116053-Humans, pubmed-meshheading:15116053-International Normalized Ratio, pubmed-meshheading:15116053-Male, pubmed-meshheading:15116053-Middle Aged, pubmed-meshheading:15116053-NAD(P)H Dehydrogenase (Quinone), pubmed-meshheading:15116053-Pharmacogenetics, pubmed-meshheading:15116053-Polymerase Chain Reaction, pubmed-meshheading:15116053-Polymorphism, Genetic
pubmed:year	2004
pubmed:articleTitle	Pharmacogenetics of acenocoumarol pharmacodynamics.
pubmed:affiliation	Pharmacology Department, Saint-Antoine University Hospital, Paris, France.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't